Complete Filing Data
Palmer Square Capital BDC Inc. reported Stockholders Equity of $464.12 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Palmer Square Capital BDC Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$3.2M | $47.7M | $107.8M | -$74.5M | $19.1M |
| Operating Expenses | $70.9M | $81.0M | $55.3M | $34.5M | $17.6M |
| Income Loss From Continuing Operations Per Diluted Share | -$0.10 | $1.47 | $4.20 | -$3.22 | $1.23 |
| Income Loss From Continuing Operations Per Basic Share | -$0.10 | $1.47 | $4.20 | -$3.22 | $1.23 |
| Other General And Administrative Expense | $3.1M | $3.1M | $1.5M | $1.9M | $1.8M |
| Interest Expense Operating | $50.1M | $58.0M | $44.5M | $23.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $3.4M | $7.2M | -$8.4M | $7.6M | $5.3M | $22.9M | $33.9M | $23.9M | $28.1M | -$6.8M | -$65.3M | -$3.4M | |
| Operating Expenses | $18.0M | $17.8M | $18.3M | $21.6M | $20.8M | $18.5M | $14.2M | $13.5M | $12.8M | $9.8M | $7.2M | $5.9M | $4.2M |
| Income Loss From Continuing Operations Per Diluted Share | $0.10 | $0.22 | -$0.26 | $0.23 | $0.16 | $0.72 | $1.30 | $0.94 | $1.14 | -$0.29 | -$2.85 | -$0.15 | $0.33 |
| Income Loss From Continuing Operations Per Basic Share | $0.10 | $0.22 | -$0.26 | $0.23 | $0.16 | $0.72 | $1.30 | $0.94 | $1.14 | -$0.29 | -$2.85 | -$0.15 | $0.33 |
| Other General And Administrative Expense | $826.7K | $797.1K | $805.3K | $896.4K | $659.2K | $722.2K | $383.8K | $350.6K | $367.0K | $551.7K | $525.2K | ||
| Interest Expense Operating | $12.8M | $12.6M | $13.0M | $15.7M | $15.0M | $13.2M | $11.5M | $10.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $464.1M | $537.8M | $462.0M | $363.4M | $452.8M | $253.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.2M | $2.8M | $2.1M | $1.7M | $1.1M | $682.6K |
| Unrealized Gain Loss On Investments | -$43.4M | $2.8M | $52.6M | -$107.4M | -$8.5M | |
| Net Increase In Net Assets From Capital Share Transactions | -$17.5M | $90.5M | $46.7M | $29.2M | $206.5M | |
| Non Affiliate Non Control Investments | -$43.4M | $2.8M | $52.6M | -$107.4M | $4.8M | |
| Increasedecrease In Receivable For Sales Of Investments | -$5.0M | $7.7M | -$30.9M | $13.6M | $5.6M | |
| Accretion Amortization Of Discounts And Premiums Investments | $2.7M | $1.4M | $1.9M | $1.7M | $286.3K | |
| Gain Loss On Investments | -$56.6M | -$14.9M | $49.8M | -$115.6M | -$3.8M | |
| Receivable For Paydowns Of Investments | $233.9K | $1.3M | $344.5K | $136.1K | $227.5K | |
| Prepaid Expense And Other Assets | $41.4K | $32.4K | $30.1K | $598.3K | $196.0K | |
| Liabilities And Stockholders Equity | $1.22B | $1.43B | $1.12B | $1.06B | $1.22B | |
| Liabilities | $755.3M | $893.2M | $659.9M | $694.0M | $764.5M | |
| Interest Receivable | $8.6M | $11.5M | $8.4M | $6.5M | $3.8M | |
| Dividends Receivable | $195.7K | $259.6K | $301.6K | $142.0K | $833.00 | |
| Common Stock Value | $31.3K | $32.6K | $27.1K | $24.3K | $22.6K | |
| Cash And Cash Equivalents At Carrying Value | $3.2M | $2.8M | $2.1M | $1.7M | $1.1M | |
| Assets | $1.22B | $1.43B | $1.12B | $1.06B | $1.22B | |
| Increasedecrease In Receivable For Paydowns Of Investments | -$1.1M | $1.0M | $208.4K | -$91.4K | $106.2K | |
| Payable Investment Purchase | $20.4M | $67.5M | $14.7M | $42.8M | $104.3M | |
| Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments | -$52.6M | $107.4M | $8.5M | |||
| Management Fee Payable | $2.1M | $2.4M | $2.3M | $1.9M | $2.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $451.0K | $649.3K | $466.3K | $557.3K | $410.9K | |
| Stockholders Equity Period Increase Decrease | -$73.7M | $75.9M | $98.5M | -$44.1M | -$26.0M | |
| Retained Earnings Accumulated Deficit | -$129.6M | -$73.3M | -$58.7M | -$110.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $490.4M | $505.2M | $515.8M | $541.9M | $548.8M | $558.5M | $446.9M | $426.5M | $402.6M | $373.9M | $385.4M | $454.2M | $312.9M | $272.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.2M | $16.4M | $2.9M | $1.8M | $14.8M | $8.3M | $3.4M | $6.7M | $6.2M | $4.2M | $99.0K | $4.7M | $11.0M | ||
| Unrealized Gain Loss On Investments | -$9.0M | -$926.4K | -$15.4M | -$1.1M | -$1.0M | $8.3M | $21.2M | $9.7M | $14.8M | -$16.7M | -$74.4M | -$11.7M | -$673.3K | ||
| Net Increase In Net Assets From Capital Share Transactions | -$4.7M | -$4.2M | -$957.4K | $925.0K | $246.9K | $89.7M | $15.1M | $13.1M | $11.1M | $5.4M | $5.0M | $4.8M | $39.5M | ||
| Non Affiliate Non Control Investments | -$9.0M | -$926.4K | -$15.4M | -$1.1M | -$1.0M | $8.3M | -$2.1M | -$2.6K | -$317.4K | -$496.7K | -$486.8K | -$369.9K | |||
| Increasedecrease In Receivable For Sales Of Investments | $6.4M | -$12.9K | -$27.0M | $12.7M | |||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $598.2K | $578.6K | $352.4K | $111.3K | |||||||||||
| Gain Loss On Investments | -$10.3M | -$6.7M | -$21.3M | -$8.2M | -$10.4M | $6.6M | $19.0M | $9.7M | $14.5M | ||||||
| Receivable For Paydowns Of Investments | $1.1M | $210.6K | $846.5K | $840.5K | $637.1K | $450.8K | $282.3K | $611.7K | $242.9K | $3.2M | |||||
| Prepaid Expense And Other Assets | $107.4K | $39.2K | $62.4K | $139.5K | $167.1K | $85.5K | $620.2K | $3.2M | $604.0K | $400.7K | |||||
| Liabilities And Stockholders Equity | $1.28B | $1.31B | $1.36B | $1.41B | $1.46B | $1.41B | $1.12B | $1.08B | $1.06B | $1.02B | |||||
| Liabilities | $791.1M | $809.6M | $847.1M | $871.6M | $910.0M | $854.0M | $677.9M | $655.1M | $657.6M | $646.0M | |||||
| Interest Receivable | $8.7M | $9.6M | $10.0M | $12.1M | $11.3M | $10.0M | $7.5M | $7.6M | $6.0M | $5.7M | |||||
| Dividends Receivable | $197.6K | $151.4K | $200.8K | $158.0K | $263.9K | $357.3K | $403.6K | $400.1K | $217.7K | $99.9K | |||||
| Common Stock Value | $31.9K | $32.2K | $32.5K | $32.6K | $32.6K | $32.6K | $26.7K | $25.8K | $25.0K | $23.4K | |||||
| Cash And Cash Equivalents At Carrying Value | $4.2M | $16.4M | $2.9M | $1.8M | $14.8M | $8.3M | $3.4M | $6.7M | $6.2M | $4.2M | |||||
| Assets | $1.28B | $1.31B | $1.36B | $1.41B | $1.46B | $1.41B | $1.12B | $1.08B | $1.06B | $1.02B | |||||
| Increasedecrease In Receivable For Paydowns Of Investments | -$501.1K | $106.3K | $106.8K | $69.7K | |||||||||||
| Payable Investment Purchase | $20.0M | $27.4M | $54.8M | $26.1M | $68.2M | $37.6M | $35.2M | $24.8M | $38.2M | ||||||
| Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments | $1.1M | $1.0M | -$8.3M | -$21.2M | -$9.7M | -$14.8M | $16.7M | $74.4M | $11.7M | ||||||
| Management Fee Payable | $2.2M | $2.2M | $2.3M | $2.4M | $2.5M | $2.4M | $2.2M | $2.0M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $106.0K | $6.1M | $4.6M | ||||||||||||
| Stockholders Equity Period Increase Decrease | -$14.8M | -$10.6M | -$6.9M | -$9.7M | -$28.6M | -$13.2M | -$10.1M | -$8.4M | |||||||
| Retained Earnings Accumulated Deficit | -$110.8M | -$100.8M | -$94.4M | -$69.6M | -$61.8M | -$51.8M | -$66.4M | -$86.1M | $8.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Increase Decrease In Other Operating Capital Net | -$3.2M | $47.7M | $107.8M | -$74.5M | $19.1M |
| Proceeds From Sale Of Short Term Investments | $597.5M | $862.3M | $565.5M | $402.2M | $637.6M |
| Proceeds From Issuance Of Common Stock | $0.00 | $89.7M | $17.7M | $5.0M | $188.9M |
| Payments To Acquire Short Term Investments | $600.8M | $868.0M | $578.7M | $374.4M | $662.6M |
| Net Cash Provided By Used In Operating Activities | $160.7M | -$200.6M | $19.5M | $25.1M | -$438.0M |
| Net Cash Provided By Used In Financing Activities | -$160.2M | $201.2M | -$19.1M | -$24.6M | $438.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $9.1K | $2.3K | -$568.2K | $402.3K | $196.0K |
| Proceeds From Lines Of Credit | $45.1M | $241.1M | $27.5M | $81.3M | $256.6M |
| Increase Decrease In Other Accrued Liabilities | -$435.1K | $300.8K | -$67.6K | -$1.0M | $1.7M |
| Increase Decrease In Interest And Dividends Receivable | -$2.9M | $3.0M | $2.1M | $2.8M | $2.2M |
| Payments Of Distributions To Affiliates | $55.3M | $46.6M | $33.9M | $18.8M | $6.3M |
| Payments Of Debt Issuance Costs | $1.2M | $5.5M | $1.8M | $0.00 | $780.6K |
| Increase Decrease In Payable For Investment Purchased | -$47.1M | $52.7M | -$28.0M | -$61.5M | $88.7M |
| Increase Decrease In Management Fee Payable | -$284.7K | $161.7K | $379.3K | -$373.1K | $1.0M |
| Increase Decrease In Interest Payable Net | -$1.9M | $3.4M | $2.3M | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Other Operating Capital Net | $3.4M | $7.2M | -$8.4M | $7.6M | $5.3M | $22.9M | $33.9M | $23.9M | $28.1M | -$6.8M | -$65.3M | |
| Proceeds From Sale Of Short Term Investments | $140.2M | $295.5M | $181.2M | $168.9M | ||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $89.7M | $11.1M | $4.8M | ||||||||
| Payments To Acquire Short Term Investments | $127.6M | $295.8M | $230.5M | $137.5M | ||||||||
| Net Cash Provided By Used In Operating Activities | $46.4M | -$237.9M | $27.9M | -$8.3M | ||||||||
| Net Cash Provided By Used In Financing Activities | -$46.3M | $244.0M | -$23.4M | $11.9M | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $30.0K | $55.4K | $5.7K | $165.5K | ||||||||
| Proceeds From Lines Of Credit | $26.6M | $158.0M | $33.0M | |||||||||
| Increase Decrease In Other Accrued Liabilities | -$394.1K | -$123.5K | -$13.9K | -$1.6M | ||||||||
| Increase Decrease In Interest And Dividends Receivable | -$1.5M | $1.7M | -$369.6K | $413.4K | ||||||||
| Payments Of Distributions To Affiliates | $15.6M | $0.00 | $6.9M | $5.9M | ||||||||
| Payments Of Debt Issuance Costs | $0.00 | $3.6M | $17.7K | |||||||||
| Increase Decrease In Payable For Investment Purchased | -$12.6M | $22.9M | -$4.6M | |||||||||
| Increase Decrease In Management Fee Payable | -$80.1K | $164.2K | $39.4K | |||||||||
| Increase Decrease In Interest Payable Net | -$428.6K | -$1.3M | $2.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $14.85 | $16.50 | $17.04 | $14.96 | $20.06 | $20.15 |
| Weighted Average Number Of Shares Outstanding Basic | 32.1M | 32.4M | 25.7M | 23.1M | 15.5M | 11.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 32.1M | 32.4M | 25.7M | 23.1M | 15.5M | |
| Common Stock Shares Outstanding | 31.3M | 32.6M | 27.1M | 24.3M | 22.8M | |
| Earnings Per Share Diluted | $1.66 | $1.93 | $2.26 | $1.78 | $1.47 | |
| Earnings Per Share Basic | $1.66 | $1.93 | $2.26 | $1.78 | $1.47 | |
| Common Stock Shares Issued | 31.3M | 32.6M | 27.1M | 24.3M | 22.6M | |
| Common Stock Shares Authorized | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $15.39 | $15.68 | $15.85 | $16.61 | $16.85 | $17.16 | $16.76 | $16.55 | $16.12 | $16.00 | $20.70 | ||
| Weighted Average Number Of Shares Outstanding Basic | 32.1M | 32.3M | 32.6M | 32.6M | 32.6M | 31.6M | 26.0M | 25.5M | 24.6M | 23.2M | 22.9M | 22.8M | 14.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 32.1M | 32.3M | 32.6M | 32.6M | 32.6M | 31.6M | 26.0M | 25.5M | 24.6M | 23.2M | 22.9M | 22.8M | 14.4M |
| Common Stock Shares Outstanding | 31.9M | 32.2M | 32.5M | 32.6M | 32.6M | 32.6M | 26.7M | 25.8M | 25.0M | 23.4M | |||
| Earnings Per Share Diluted | $0.43 | $0.43 | $0.40 | $0.48 | $0.48 | $0.52 | $0.57 | $0.56 | $0.55 | ||||
| Earnings Per Share Basic | $0.43 | $0.43 | $0.40 | $0.48 | $0.48 | $0.52 | $0.57 | $0.56 | $0.55 | ||||
| Common Stock Shares Issued | 31.9M | 32.2M | 32.5M | 32.6M | 32.6M | 32.6M | 26.7M | 25.8M | 25.0M | 23.4M | |||
| Common Stock Shares Authorized | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Investment Income | $53.5M | $62.6M | $58.0M | $41.1M | $22.8M |
| Realized Investment Gains Losses | -$13.2M | -$17.8M | -$2.7M | -$8.1M | $4.8M |
| Professional Fees | $1.1M | $1.5M | $792.6K | $742.0K | $758.4K |
| Other Income | $2.2M | $1.6M | $417.5K | $184.2K | $778.8K |
| Noninterest Expense Directors Fees | $150.0K | $150.0K | $75.0K | $75.0K | $75.0K |
| Management Fee Expense | $8.9M | $9.7M | $8.4M | $8.3M | $6.4M |
| Investment Income Net | $124.4M | $143.5M | $112.2M | $74.5M | $39.7M |
| Investment Income Dividend | $2.3M | $3.3M | $4.1M | $610.2K | $9.6K |
| Interest And Other Income | $118.3M | $137.5M | $107.7M | $73.7M | $38.9M |
| Other Operating Income | $0.00 | $50.5K | $1.1M | $1.0M | $796.2K |
| Stock Issued During Period Value Dividend Reinvestment Plan | $514.6K | $2.1M | $29.1M | $24.2M | |
| Dividends And Distributions To Stockholders | -$53.1M | -$62.2M | -$56.1M | -$43.1M | $17.8M |
| Stock Issued During Period Value New Issues | $0.00 | $89.7M | $17.7M | $5.0M | $188.9M |
| Other Operating Income Expense Net | -$70.9M | -$80.9M | -$54.2M | -$33.4M | -$16.9M |
| Interest Paid Net | $52.0M | $54.6M | $42.2M | $22.3M | $7.3M |
| Increase Decrease Due From Affiliates | $368.6K | -$1.5M | $1.5M | -$46.6K | $125.4K |
| Gross Investment Income Operating | $124.4M | $143.5M | $112.2M | $74.5M | $39.7M |
| Line Of Credit | $414.4M | $501.7M | $641.8M | $641.3M | $649.9M |
| Investment Owned At Fair Value | $1.20B | $1.41B | $1.11B | $1.02B | $1.19B |
| Investment Owned At Cost | $1.29B | $1.45B | $1.16B | $1.12B | $1.19B |
| Repayments Of Lines Of Credit | $131.3M | $378.2M | $28.5M | $92.0M | |
| Amortization Of Financing Costs | $1.7M | $1.6M | $1.0M | $988.2K | $909.3K |
| Distributions Declared During The Period | $53.1M | $62.2M | $56.1M | $44.1M | $26.0M |
| Incentive Fee Expense | $7.6M | $8.6M | $0.00 | $0.00 | |
| Reinvestment Of Distributions During The Period | $0.00 | $0.00 | $29.1M | $24.2M | $17.7M |
| Interest Income Operating Paid In Kind | $1.6M | $1.1M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Investment Income | $13.1M | $13.6M | $13.8M | $12.9M | $14.8M | $15.7M | $15.8M | $16.3M | $15.4M | $14.8M | $14.2M | $13.6M | $10.5M | $9.5M | $8.7M | $4.9M |
| Realized Investment Gains Losses | -$1.2M | -$5.7M | -$5.9M | -$7.1M | -$9.4M | -$1.7M | -$2.1M | -$2.6K | -$317.4K | -$496.7K | -$486.8K | -$369.9K | $489.6K | |||
| Professional Fees | $229.1K | $251.4K | $312.7K | $318.5K | $398.1K | $237.9K | $143.6K | $207.3K | $212.0K | $184.7K | $140.0K | $138.4K | $172.7K | |||
| Other Income | $235.0K | $369.7K | $312.4K | $726.2K | $283.9K | $270.3K | $152.8K | $133.2K | $55.9K | $31.3K | $56.1K | $93.0K | $150.5K | |||
| Noninterest Expense Directors Fees | $37.8K | $37.4K | $37.0K | $37.7K | $37.3K | $37.3K | $18.9K | $18.7K | $18.5K | $18.9K | $18.7K | $18.5K | $20.2K | |||
| Management Fee Expense | $2.2M | $2.2M | $2.3M | $2.4M | $2.5M | $2.4M | $2.2M | $2.0M | $1.9M | $2.0M | $2.2M | $2.3M | $1.5M | |||
| Investment Income Net | $31.7M | $31.7M | $31.2M | $37.3M | $36.5M | $34.8M | $28.8M | $27.4M | $26.2M | $20.0M | $16.5M | $14.3M | $8.9M | |||
| Investment Income Dividend | $657.2K | $481.5K | $574.3K | $599.7K | $805.0K | $1.3M | $1.3M | $1.1M | $676.9K | $223.8K | $50.1K | $4.6K | $2.8K | |||
| Interest And Other Income | $30.4M | $30.0M | $29.8M | $35.8M | $35.3M | $33.3M | $27.3M | $26.2M | $25.5M | $19.7M | $16.4M | $14.2M | $8.7M | |||
| Other Operating Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.5K | $274.7K | $255.8K | $239.0K | $250.0K | $274.7K | $282.2K | $186.3K | |||
| Stock Issued During Period Value Dividend Reinvestment Plan | $0.00 | $0.00 | $514.6K | $1.1M | $593.2K | $0.00 | $14.7M | $6.9M | $5.4M | $5.0M | $2.3M | |||||
| Dividends And Distributions To Stockholders | -$13.4M | -$13.5M | -$12.7M | -$15.3M | -$15.3M | -$16.0M | -$28.6M | -$13.2M | -$10.1M | -$8.4M | ||||||
| Stock Issued During Period Value New Issues | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $89.7M | $350.0K | $6.2M | $11.1M | $37.2M | ||||||
| Other Operating Income Expense Net | -$18.0M | -$17.8M | -$18.3M | -$21.6M | -$20.8M | -$18.5M | -$14.0M | -$13.2M | -$12.6M | -$9.5M | ||||||
| Interest Paid Net | $13.4M | $14.5M | $7.9M | $3.5M | ||||||||||||
| Increase Decrease Due From Affiliates | $214.7K | -$1.6M | $4.9K | $1.5K | ||||||||||||
| Gross Investment Income Operating | $31.7M | $31.7M | $31.2M | $37.3M | $36.5M | $34.8M | $28.8M | $27.4M | $26.2M | |||||||
| Line Of Credit | $450.1M | $461.1M | $472.3M | $518.5M | $519.9M | $795.2M | $632.5M | $627.4M | $616.4M | $637.1M | ||||||
| Investment Owned At Fair Value | $1.26B | $1.28B | $1.33B | $1.39B | $1.43B | $1.39B | $1.10B | $1.06B | $1.04B | $1.01B | ||||||
| Investment Owned At Cost | $1.33B | $1.34B | $1.40B | $1.43B | $1.47B | $1.44B | $1.16B | $1.14B | $1.13B | $1.10B | ||||||
| Repayments Of Lines Of Credit | $56.3M | $0.00 | $27.5M | $20.0M | ||||||||||||
| Amortization Of Financing Costs | $424.7K | $289.6K | $245.0K | $243.7K | ||||||||||||
| Distributions Declared During The Period | $12.7M | $16.0M | ||||||||||||||
| Incentive Fee Expense | $2.0M | $1.9M | $1.8M | $2.2M | $2.2M | $1.9M | $0.00 | |||||||||
| Reinvestment Of Distributions During The Period | $0.00 | $0.00 | ||||||||||||||
| Interest Income Operating Paid In Kind | $360.9K | $801.9K | $507.9K | $204.8K | $182.1K | $0.00 | $0.00 |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.